Carbocysteine

Carbocysteine

SCHEMBL19614508

N[C@H](CSCC(=O)O)C(=O)O.[NaH]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BHMT Q93088 6/20 0.57
ARG1 P05089 1/20 0.52
ARG2 P78540 1/20 0.52
CYP2D6 P10635 1/20 0.48
HIF1A Q16665 1/20 0.48
NOS2 P35228 3/20 0.46
NOS1 P29475 2/20 0.46
NOS3 P29474 1/20 0.46
GRM8 O00222 1/20 0.43
GRM6 O15303 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GSR P00390 1/20 0.43
CYP1A2 P05177 1/20 0.43
GRIK1 P39086 1/20 0.43
GRM5 P41594 1/20 0.43
GRIA1 P42261 1/20 0.43
GRIA2 P42262 1/20 0.43
GRIA3 P42263 1/20 0.43
SLC1A3 P43003 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbocysteine SCHEMBL20854 0.98 BHMT (0.59) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL69149 0.98 BHMT (0.59) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL9236855 0.98 BHMT (0.59) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL6762355 0.98 BHMT (0.59) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614516 0.95 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614546 0.95 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614495 0.95 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL15545269 0.95 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614507 0.95 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614544 0.95 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10251854-B2 S-(carboxymethyl)-cysteine pharmaceutical compound and preparation method and use thereof Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (CN) 2019-04-09 US disclosed
US-20170333374-A1 S-(CARBOXYMETHYL)-CYSTEINE PHARMACEUTICAL COMPOUND AND PREPARATION METHOD AND USE THEREOF GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD., BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY (CN) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333374-A1 S-(CARBOXYMETHYL)-CYSTEINE PHARMACEUTICAL COMPOUND AND PREPARATION METHOD AND USE THEREOF CBS, SRM, CTH BHMT 51/4885ARG1 223/4885ARG2 92/4885
US-10251854-B2 S-(carboxymethyl)-cysteine pharmaceutical compound and preparation method and use thereof CBS, SRM, CTH BHMT 51/4885ARG1 223/4885ARG2 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.